S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jerry Radich, MD
Fred Hutchinson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
91 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Cancer Center
Anchorage, Alaska, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
Orange, California, United States
- Stanford Cancer Center
Stanford, California, United States
- M.D. Anderson Cancer Center at Orlando
Orlando, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Northside Hospital Cancer Center
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Wellstar Cobb Hospital
Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at Dekalb Medical Center
Decatur, Georgia, United States
- Gwinnett Medical Center
Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
- Southern Regional Medical Center
Riverdale, Georgia, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
- Reid Hospital & Health Care Services
Richmond, Indiana, United States
- Cancer Center of Kansas, Pa - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas, Pa - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas, Pa - El Dorado
El Dorado, Kansas, United States
- Cancer Center of Kansas, Pa - Kingman
Kingman, Kansas, United States
- Southwest Medical Center
Liberal, Kansas, United States
- Cancer Center of Kansas, Pa - Newton
Newton, Kansas, United States
- Cancer Center of Kansas, Pa - Parsons
Parsons, Kansas, United States
- Cancer Center of Kansas, Pa - Pratt
Pratt, Kansas, United States
- Cancer Center of Kansas, Pa - Salina
Salina, Kansas, United States
- Tammy Walker Cancer Center at Salina Regional Health Center
Salina, Kansas, United States
- Cancer Center of Kansas, Pa - Wellington
Wellington, Kansas, United States
- Associates in Womens Health, Pa - North Review
Wichita, Kansas, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Medical Arts Tower
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Wichita
Wichita, Kansas, United States
- Via Christi Cancer Center at Via Christi Regional Medical Center
Wichita, Kansas, United States
- Wesley Medical Center
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Winfield
Winfield, Kansas, United States
- Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Billings Clinic - Downtown
Billings, Montana, United States
- Ccop - Montana Cancer Consortium
Billings, Montana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2006
- Primary completion
- 31 Dec 2008
- Completion
- 31 Jan 2013
- Last update posted
- 25 Mar 2015
- Registered enrollment
- 36
- Registry id
- NCT00337168
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.